Metraipolis › archive › dc_cdc16f0bb82e
Pulmonary Embolism in Antiphospholipid Syndrome (APS)-Where Are We and Where Are We Going? — Europe PMC PMID:41596541
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41596541
- DOI
- 10.3390/ijms27020895
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T19:19:34.908Z
- SHA-256 of the archived text
7904884a3bbd20294c80fe2b5d237ecd3f847616b388d532d78a00b45330242a- Stable URL of this page
https://metraipolis.com/documento/dc_cdc16f0bb82e
How to cite
Pulmonary Embolism in Antiphospholipid Syndrome (APS)-Where Are We and Where Are We Going? — Europe PMC PMID:41596541 — Europe PMC (en), https://europepmc.org/article/MED/41596541 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cdc16f0bb82e (Metraipolis archive dc_cdc16f0bb82e, sha256 7904884a3bbd20294c80fe2b5d237ecd3f847616b388d532d78a00b45330242a)
BibTeX
@misc{dccdc16f0bb82e,
title = {Pulmonary Embolism in Antiphospholipid Syndrome (APS)-Where Are We and Where Are We Going? — Europe PMC PMID:41596541},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41596541},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cdc16f0bb82e; sha256 7904884a3bbd20294c80fe2b5d237ecd3f847616b388d532d78a00b45330242a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41596541. Agents can read the archived copy with the MCP tool read_document.